FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 147 filers reported holding FLEXION THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $299,000 | +49.5% | 49,022 | +102.2% | 0.00% | – |
Q2 2021 | $200,000 | +28.2% | 24,242 | +38.9% | 0.00% | – |
Q1 2021 | $156,000 | -22.4% | 17,458 | 0.0% | 0.00% | – |
Q4 2020 | $201,000 | +10.4% | 17,458 | 0.0% | 0.00% | – |
Q3 2020 | $182,000 | -20.9% | 17,458 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $230,000 | +67.9% | 17,458 | 0.0% | 0.00% | – |
Q1 2020 | $137,000 | -62.0% | 17,458 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $361,000 | +51.0% | 17,458 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $239,000 | +11.2% | 17,458 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $215,000 | +3.4% | 17,458 | +4.7% | 0.00% | 0.0% |
Q1 2019 | $208,000 | +10.1% | 16,668 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $189,000 | -36.4% | 16,668 | +4.9% | 0.00% | 0.0% |
Q3 2018 | $297,000 | -27.7% | 15,896 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $411,000 | +41.7% | 15,896 | +22.9% | 0.00% | 0.0% |
Q1 2018 | $290,000 | -4.6% | 12,936 | +6.6% | 0.00% | 0.0% |
Q4 2017 | $304,000 | +29.4% | 12,138 | +24.6% | 0.00% | 0.0% |
Q3 2017 | $235,000 | – | 9,738 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 1,500,000 | $36,270,000 | 4.72% |
Gagnon Advisors, LLC | 108,498 | $2,623,000 | 1.99% |
NEXTHERA CAPITAL LP | 271,136 | $6,556,000 | 1.69% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 883,321 | $21,359,000 | 1.39% |
GILDER GAGNON HOWE & CO LLC | 3,961,647 | $95,793,000 | 1.35% |
GAGNON SECURITIES LLC | 144,331 | $3,490,000 | 1.30% |
MILLER VALUE PARTNERS, LLC | 1,181,325 | $28,564,000 | 1.23% |
SCHOLTZ & COMPANY, LLC | 55,250 | $1,336,000 | 1.05% |
ARDSLEY ADVISORY PARTNERS LP | 175,000 | $4,232,000 | 0.56% |
Ratan Capital Management LP | 32,077 | $776,000 | 0.47% |